Healthcare >> CEO Interviews >> April 28, 2003
ALBERT D. FRIESEN is Chairman, President and Chief Executive Officer of
Medicure Inc. He holds a PhD in Protein Chemistry from the University of
Manitoba. He was the first employee and President of Winnipeg Rh
Institute, developer of the WinRho series of drugs; the company was
acquired by Cangene in 1990. He is the Founder and former President and
CEO of ABI Biotechnology, whose assets were acquired by Apotex Inc. in
1991; and he is the former President of Novopharm Biotech Inc., a
position held until 1997. In addition, he is the Founder of the
Industrial Biotechnology Association of Canada, and he has also served
on the Advisory Committee of Montreal's Biotechnology Research
Institute. In 1997, he co-founded Medicure Inc. Profile
drivers are?
Dr. Friesen: The company is focused on the development of
cardiovascular drugs. Our mission statement says
